These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6586753)

  • 1. Vertebral abnormalities associated with synthetic retinoid use.
    Gerber LH; Helfgott RK; Gross EG; Hicks JE; Ellenberg SS; Peck GL
    J Am Acad Dermatol; 1984 May; 10(5 Pt 1):817-23. PubMed ID: 6586753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraspinal tendon and ligament calcification associated with long-term therapy with etretinate.
    DiGiovanna JJ; Helfgott RK; Gerber LH; Peck GL
    N Engl J Med; 1986 Nov; 315(19):1177-82. PubMed ID: 3463863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal changes associated with chronic isotretinoin and etretinate administration.
    McGuire J; Lawson JP
    Dermatologica; 1987; 175 Suppl 1():169-81. PubMed ID: 3121403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skeletal changes following long-term treatment with retinoids].
    Montag M; Reiser M; Hamm H; Traupe H; Vogt HJ
    Radiologe; 1988 Jul; 28(7):320-5. PubMed ID: 3045876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extensive spinal hyperostosis in a patient receiving isotretinoin--progression after 4 years of etretinate therapy.
    Archer CB; Elias PM; Lowe NJ; Griffiths WA
    Clin Exp Dermatol; 1989 Jul; 14(4):319-21. PubMed ID: 2591100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term radiographic follow-up after isotretinoin therapy.
    Ellis CN; Pennes DR; Hermann RC; Blauvelt A; Martel W; Voorhees JJ
    J Am Acad Dermatol; 1988 Jun; 18(6):1252-61. PubMed ID: 2968377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged treatment with oral retinoids in adults: no influence on the frequency and severity of spinal abnormalities.
    Van Dooren-Greebe RJ; Lemmens JA; De Boo T; Hangx NM; Kuijpers AL; Van de Kerkhof PC
    Br J Dermatol; 1996 Jan; 134(1):71-6. PubMed ID: 8745889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retinoids.
    Roenigk HH
    Cutis; 1987 Apr; 39(4):301-5. PubMed ID: 3472776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spermatological investigations in patients treated with etretinate and isotretinoin.
    Török L; Kádár L; Kása M
    Andrologia; 1987; 19(6):629-33. PubMed ID: 3481225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of retinoids in bone.
    Kilcoyne RF
    J Am Acad Dermatol; 1988 Jul; 19(1 Pt 2):212-6. PubMed ID: 2970477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A sequential comparison of etretinate (Tigason) and isotretinoin (Roaccutane) with special regard to their effects on serum lipoproteins.
    Vahlquist C; Michaëlsson G; Vahlquist A; Vessby B
    Br J Dermatol; 1985 Jan; 112(1):69-76. PubMed ID: 3882125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoporosis is a toxic effect of long-term etretinate therapy.
    DiGiovanna JJ; Sollitto RB; Abangan DL; Steinberg SM; Reynolds JC
    Arch Dermatol; 1995 Nov; 131(11):1263-7. PubMed ID: 7503569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.
    Vahlquist A; Lööf L; Nordlinder H; Rollman O; Vahlquist C
    Acta Derm Venereol; 1985; 65(4):359-62. PubMed ID: 2413699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Complications of retinoid treatment in children].
    Doutre MS; Beylot C
    Ann Pediatr (Paris); 1988 May; 35(5):367-9. PubMed ID: 3165253
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimal spinal hyperostosis with low-dose isotretinoin therapy.
    Kilcoyne RF; Cope R; Cunningham W; Nardella FA; Denman S; Franz TJ; Hanifin J
    Invest Radiol; 1986 Jan; 21(1):41-4. PubMed ID: 2935510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nature of skin fragility in patients receiving retinoids for systemic effect.
    Williams ML; Elias PM
    Arch Dermatol; 1981 Oct; 117(10):611-9. PubMed ID: 6945067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years' experience on 23 patients.
    Katugampola RP; Finlay AY
    Br J Dermatol; 2006 Feb; 154(2):267-76. PubMed ID: 16433796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal hyperostosis and extraosseous calcification in patients receiving long-term etretinate (Tigason).
    Wilson DJ; Kay V; Charig M; Hughes DG; Creasy TS
    Br J Dermatol; 1988 Nov; 119(5):597-607. PubMed ID: 3207613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature.
    Halverstam CP; Zeichner J; Lebwohl M
    J Cutan Med Surg; 2006; 10(6):291-9. PubMed ID: 17241599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effect of isotretinoin and etretinate on acne and sebaceous gland secretion.
    Goldstein JA; Socha-Szott A; Thomsen RJ; Pochi PE; Shalita AR; Strauss JS
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):760-5. PubMed ID: 6461679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.